We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$20.3B
Cap. Flow %
2.85%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.94%
2 Technology 1.9%
3 Communication Services 1.42%
4 Financials 1.08%
5 Healthcare 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAVE icon
12226
CALL
RAVE Restaurant Group
RAVE
$44.3M
$48K ﹤0.01%
+32,700
New +$45.3K
TH icon
12227
Target Hospitality
TH
$1.73B
$48K ﹤0.01%
+12,815
New +$42.4K
TTNP
12228
PUT
DELISTED
Titan Pharmaceuticals
TTNP
$48K ﹤0.01%
920
-5,420
-85% -$271K
FAZEW
12229
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$48K ﹤0.01%
+38,138
New +$38.7K
ACII.WS
12230
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
$48K ﹤0.01%
+41,878
New +$44.1K
KCAC.WS
12231
DELISTED
Kensington Capital Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one
KCAC.WS
$48K ﹤0.01%
+28,070
New +$52.8K
TWAV
12232
TaoWeave Inc
TWAV
$5.43M
$47K ﹤0.01%
+23
New +$55.7K
PVL
12233
CALL
Permianville Royalty Trust
PVL
$59.7M
$47K ﹤0.01%
24,100
-6,800
-22% -$11.2K
REFR icon
12234
CALL
Research Frontiers
REFR
$16.7M
$47K ﹤0.01%
19,800
-28,900
-59% -$72K
TTI icon
12235
TETRA Technologies
TTI
$1B
$47K ﹤0.01%
10,793
-240,330
-96% -$792K
MOTV.WS
12236
DELISTED
Motive Capital Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an ex
MOTV.WS
$47K ﹤0.01%
49,067
SBBP
12237
CALL
DELISTED
Strongbridge Biopharma plc.
SBBP
$47K ﹤0.01%
15,900
-1,600
-9% -$4.22K
QUAD icon
12238
Quad
QUAD
$526M
$46K ﹤0.01%
+11,125
New +$40.3K
RCMT icon
12239
CALL
RCM Technologies
RCMT
$299M
$46K ﹤0.01%
11,100
-1,700
-13% -$6.25K
RMTI icon
12240
Rockwell Medical
RMTI
$32M
$46K ﹤0.01%
464
-380
-45% -$39.2K
EMBKW
12241
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$46K ﹤0.01%
+27,772
New +$41.9K
MBIO icon
12242
CALL
Mustang Bio
MBIO
$4.18M
$45K ﹤0.01%
18
-58
-76% -$142K
AUS.WS
12243
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$45K ﹤0.01%
+25,781
New +$37.3K
PLM
12244
DELISTED
PolyMet Mining Corp.
PLM
$45K ﹤0.01%
+12,408
New +$39K
FREEW
12245
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$44K ﹤0.01%
+19,689
New +$39.1K
BIOC
12246
DELISTED
Biocept, Inc.
BIOC
$44K ﹤0.01%
347
-1,986
-85% -$269K
JG
12247
CALL
Aurora Mobile
JG
$40.5M
$43K ﹤0.01%
660
+75
+13% +$4.99K
LITS
12248
PUT
Lite Strategy Inc
LITS
$35.7M
$43K ﹤0.01%
755
-35
-4% -$2.25K
IO
12249
PUT
DELISTED
ION Geophysical Corporation
IO
$43K ﹤0.01%
20,500
+4,800
+31% +$10.3K
CDTX
12250
PUT
DELISTED
Cidara Therapeutics
CDTX
$42K ﹤0.01%
+1,040
New +$44K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.